Silence Therapeutics plc - 8-K Filing

Silence Therapeutics agreed to a $6.67 per share buyout by Merck KGaA via a UK scheme of arrangement. (Items: 1.01 Entry into a Material Definitive Agreement, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR · October 19, 2026, 12:06 UTC

Tickers: $SLN

Read the full article at SEC EDGAR

Part of the story Silence Therapeutics plc - 8-K Filing (3 articles)

More Regulatory news

NVIDIA CORP - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
COVENANT LOGISTICS GROUP, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
CuriosityStream Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:52 UTC
Star Equity Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
DeFi Development Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:51 UTC
BALTIC INTERNATIONAL USA INC - 10-Q Filing SEC EDGAR · November 12, 2026, 13:49 UTC
Forbright, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:50 UTC
Boxlight Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:50 UTC
CuriosityStream Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:49 UTC
BORGWARNER INC - 8-K Filing SEC EDGAR · November 12, 2026, 13:47 UTC